Kewaunee Buys Lab Dealer Nycom for $55 Million
Lab equipment buyers and dealers should watch how the combined supply and distribution channel changes pricing and service.
Updated on Nov. 2, 2026 in Public Companies
Statesville-based Kewaunee Scientific plans to acquire Nycom, the largest U.S. lab dealer, for $55 million. The deal, expected to close in the fourth quarter of fiscal 2027, will reach North Carolina-headquartered lab equipment makers and their dealer channels.
Why it matters
The acquisition brings Kewaunee's manufacturing reach under the control of a national lab dealer, combining the supply and distribution sides of the lab furniture and equipment market. The two companies have partnered since 2012, so the move formalizes an existing working relationship rather than introducing a new one.
The $55 million base price is split into $20 million in a subordinated note, $5 million in Kewaunee stock, and a cash remainder funded from balance-sheet cash and PNC Bank borrowings. Kewaunee, with 755 U.S. and 476 international employees, saw its shares rise 5.2% to about $34.72 on Monday, within a 52-week range of $32 to $43.36.
The players
Kewaunee Scientific
Statesville, North Carolina-based manufacturer of laboratory furniture and equipment with operations in Minnesota, Charlotte, India, Spain, Singapore and Saudi Arabia.
Nycom
Midlothian, Virginia-based company described as the largest U.S. lab dealer, serving as the acquisition target.
PNC Bank
Large U.S. commercial bank providing borrowings toward the cash portion of the Kewaunee purchase price.
The details
Kewaunee will pay part of the price with a subordinated promissory note issued at closing, which ranks behind senior debt and shifts repayment risk to the seller side of the deal. The remaining purchase price is subject to adjustment against Nycom's earnings and balance-sheet position at closing, so the final figure may move. Kewaunee plans to use Nycom's operating platform to drive organic growth and pursue selective acquisitions across North America.
Timeline
Monday: Kewaunee shares traded near $34.72, up 5.2%, following the announcement.
Fourth quarter of fiscal 2027: Expected closing of the transaction.
Market Landscape
The deal continues a pattern in which a manufacturer and a distributor that already work together consolidate, as Kewaunee's long partnership with Nycom since 2012 now becomes an ownership relationship. Kewaunee's stated plan to use Nycom's platform for selective North American acquisitions positions the combined company as a consolidator in lab equipment distribution.
Operators in lab furniture and equipment supply should watch how the Nycom integration affects dealer terms and pricing in the channel. Companies that buy through Kewaunee or Nycom should monitor adjustments to pricing and service as the deal approaches its fourth quarter fiscal 2027 closing.
The takeaway
Watch how the combined company's supply and distribution terms evolve before the expected closing in the fourth quarter of fiscal 2027. Business owners who depend on these lab suppliers should review contracts for any clauses tied to change of control or pricing, and consult qualified counsel on any contract questions.
Further reading
For more on how North Carolina's listed firms handle deals like this, see Public Companies coverage.
Source note: This article includes information reported by Business North Carolina.
